The agency spotted seven observations at Dr. Reddy’s Bachupally, Hyderabad, biologics plant following a mid-June inspection. More: FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483 Source: fierce
read moreThe European Commission has kicked off formal proceedings in an antitrust investigation against Sanofi. The probe surrounds the French drugmaker’s marketing of its flu vaccine for at-risk seniors, Efluelda. More: Sanofi under antitrust probe as European Commission kicks off formal
read moreAs Amgen prepares to defend Tavneos’ market approval in the U.S., the company has received a bad omen overseas, with regulators recommending that the ANCA-associated vasculitis drug lose its authorization in the European Union after a new review led to
read moreIn the past two weeks, CARsgen won the world’s first approval for a solid tumor CAR-T, a behind-the-scenes look at Pfizer and Innovent Biologics’ $10.5 billion cancer deal revealed a less-than-five-month sprint, Daiichi Sankyo’s new R&D chief discussed how he
read moreEli Lilly is having a Total Recall moment, using cutting-edge technology to bring real, undocumented memories to life as it looks to boost awareness of Alzheimer’s disease. More: Eli Lilly taps AI to bring personal memories to life during its
read more© 1994 - 2026 B.M. Pharmaceuticals